These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12108919)

  • 1. Increased pulmonary toxicity results from a 1-day versus 2-day schedule of administration of high-dose melphalan.
    Williams L; Beveridge RA; Rifkin RM; Bretzel RL; Cuasay L; Alley JL; McGuirk J
    Biol Blood Marrow Transplant; 2002; 8(6):334-5. PubMed ID: 12108919
    [No Abstract]   [Full Text] [Related]  

  • 2. [High-dose melphalan in patients with multiple myeloma].
    Moreau P; Le Bonniec M; Harousseau JL
    Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
    Imataki O; Aoyama T; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1633-6. PubMed ID: 17940379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
    Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
    J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose melphalan and the development of hematopoietic stem-cell transplantation: 25 years later.
    Lazarus HM; Phillips GL; Herzig RH; Hurd DD; Wolff SN; Herzig GP
    J Clin Oncol; 2008 May; 26(14):2240-3. PubMed ID: 18467711
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous melphalan, thalidomide and prednisone in refractory and relapsed multiple myeloma.
    Palumbo A; Avonto I; Bruno B; Ambrosini MT; Bringhen S; Cavallo F; Falco P; Boccadoro M
    Eur J Haematol; 2006 Apr; 76(4):273-7. PubMed ID: 16519697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous stem cell transplantation in multiple myeloma - pro].
    Goldschmidt H
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1942. PubMed ID: 19760555
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
    Gupta S; Zhou P; Hassoun H; Kewalramani T; Reich L; Costello S; Drake L; Klimek V; Dhodapkar M; Teruya-Feldstein J; Hedvat C; Kalakonda N; Fleisher M; Filippa D; Qin J; Nimer SD; Comenzo RL
    Bone Marrow Transplant; 2005 Mar; 35(5):441-7. PubMed ID: 15640822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryotherapy for the prevention of high-dose melphalan-induced oral mucositis.
    Mori T; Aisa Y; Yamazaki R; Mihara A; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2006 Nov; 38(9):637-8. PubMed ID: 16953203
    [No Abstract]   [Full Text] [Related]  

  • 10. Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation.
    Akasheh MS; Freytes CO; Vesole DH
    Bone Marrow Transplant; 2000 Nov; 26(10):1107-9. PubMed ID: 11108311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards!
    Mohty M
    Leukemia; 2009 Oct; 23(10):1689-90. PubMed ID: 19826430
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma.
    Bishton M; Gilyead M; Das Gupta E; Williams C; Russell NH; Byrne JL
    Leuk Res; 2007 Aug; 31(8):1063-8. PubMed ID: 17324463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of interstitial pneumonitis after tandem high-dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma.
    Buxhofer-Ausch V; Ruckser R; Kier P; Habertheuer KH; Zelenka P; Tatzreiter G; Ausch C; Schmid I; Hruby W; Reiner-Concin A; Sebesta C; Ogris E; Hinterberger-Fischer M; Hinterberger W
    Eur J Haematol; 2004 Aug; 73(2):143-6. PubMed ID: 15245515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of transplant in multiple myeloma.
    Barlogie B
    Clin Adv Hematol Oncol; 2005 Aug; 3(8):604-6. PubMed ID: 16167043
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.
    Mellqvist UH; Lenhoff S; Johnsen HE; Hjorth M; Holmberg E; Juliusson G; Tangen JM; Westin J;
    Cancer; 2008 Jan; 112(1):129-35. PubMed ID: 17973267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
    Carreras E; Rosiñol L; Terol MJ; Alegre A; de Arriba F; García-Laraña J; Bello JL; García R; León A; Martínez R; Peñarrubia MJ; Poderós C; Ribas P; Ribera JM; San Miguel J; Bladé J; Lahuerta JJ;
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1448-54. PubMed ID: 18022574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
    Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
    Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nutritional pathway for autologous stem cell transplantation].
    Aoyama T; Imataki O; Inoue N; Katsumata M; Katsuta T; Kataoka T; Yoshida T; Mochizuki T; Motokawa S; Tamai Y; Hagiwara S; Kawakami K
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1249-53. PubMed ID: 17687206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous PBSCT in patients with cardiac amyloidosis.
    Stevens JM; Patton WN; Heaton DC; Spearing RL; Shaw G; Bowie D; Smyth D; Comenzo R
    Bone Marrow Transplant; 2000 Sep; 26(5):588-9. PubMed ID: 11019855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.